Adoptively transferred tumor-primed T cells recognize the neoantigen–HLA class II complex via their native TCR and directly kill target cells through perforin/granzyme release and Fas–FasL–mediated apoptosis, with cytokines (e.g., IFN-γ, TNF) augmenting cytotoxicity.